TFF Pharmaceuticals Awarded $2.97 Million to Develop Universal Influenza Vaccine

Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://tffpharma.com/press_releases/tff-pharmaceuticals-awarded-2-97-million-to-develop-universal-influenza-vaccine/
Research Institution
TFF Pharmaceuticals
Short Title
TFF Pharmaceuticals Awarded $2.97 Million to Develop Universal Influenza Vaccine
Content Coordinator
Claudia Wair